| Filed pursuant to Rule 424(b)(3)
Registration No. 333-103155 |
PRICING SUPPLEMENT NO. 1
to the
Prospectus dated August 6, 2003
And the Prospectus Supplement dated October 1, 2003
Universal Corporation
$400,000,000
Medium-Term Notes, Series C
The notes being purchased have the following terms:
PRINCIPAL AMOUNT: $200,000,000
STATED MATURITY: October 15, 2013
SPECIFIED CURRENCY: U.S. Dollars
FIXED INTEREST RATE: 5.200% per annum
ORIGINAL ISSUE DATE: October 7, 2003
TIME OF SALE: October 2, 2003
TIME OF DELIVERY: October 7, 2003
CUSIP: 91345H AT 2
| PRICE TO PUBLIC : |
$199,318,000, plus accrued interest from and including the Original Issue Date, if any; 99.659% per Note, plus accrued interest from and including the Original Issue Date, if any. |
| AUTHORIZED DENOMINATIONS: |
Minimum denominations of $1,000 and integral multiples thereof. |
| UNDERWRITERS: |
Deutsche Bank Securities Inc., Wachovia Capital Markets, LLC, ABN AMRO Incorporated, UBS Securities LLC, Scotia Capital (USA) Inc. and SunTrust Capital Markets, Inc. |
UNDERWRITERS’ DISCOUNT: $1,250,000 in the aggregate; 0.625% per Note
NET PROCEEDS TO UNIVERSAL CORPORATION: $ 198,068,000 in the aggregate; 99.034% per Note
THIS OFFERING IS SUBJECT TO REOPENING AT A LATER TIME TO OFFER ADDITIONAL NOTES HAVING THE SAME TERMS AS THE NOTES BEING PURCHASED.
DEPOSITARY: DTC
FORM OF NOTE:
- global registered book-entry form only: Yes
- non-global form available: Upon certain events as described in the Prospectus
- bearer note: No
REDEMPTION AND REPAYMENT: Not redeemable or repayable prior to stated maturity
SINKING FUND PROVISIONS: No sinking fund provisions
FIXED RATE NOTES:
- annual rate: 5.200%
- interest payment dates: Each April 15 and October 15, commencing April 15, 2004
- regular record date: Close of business on the 15th calendar day next preceding the interest payment date
DEFEASANCE AND COVENANT DEFEASANCE:
The Company may effect defeasance or covenant defeasance with respect to the Notes upon meeting certain conditions as set forth in the Indenture.
OTHER INFORMATION:
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved these securities or passed upon the adequacy or accuracy of the Prospectus, the Prospectus Supplement or this Pricing Supplement. Any representation to the contrary is a criminal offense.
Terms used and not defined herein but defined in the Prospectus Supplement and Prospectus are used herein as therein defined.
UNIVERSAL CORPORATION
Pricing Supplement dated October 2, 2003